Securities Class Actions · Derivative · M&A · §220 Demands

Standing Guard for Investors.

Amparo Investor Rights represents shareholders harmed by corporate misconduct — securities fraud, breach of fiduciary duty, and merger-related disclosure violations. Federal-court-trained advocacy. Contingency fee. No out-of-pocket cost to clients.

Attorney Advertising. Prior results do not guarantee a similar outcome.

What we do

When a public company misleads its shareholders, hides material information, or runs roughshod over its fiduciary duties, the shareholders harmed by that conduct have a legal path to recovery — and the cost of pursuing that path falls on us, not on you.

Amparo Investor Rights handles four categories of investor cases.

01 · Securities Class Actions

Section 10(b) & Rule 10b-5 claims

Federal securities fraud claims under Section 10(b) of the Exchange Act and SEC Rule 10b-5. When a company’s executives knowingly misled investors about material facts and the truth came out causing share price decline, investors who bought shares during the misstatement period may have claims. We investigate and, where appropriate, pursue lead plaintiff appointment under the PSLRA.

02 · Shareholder Derivative

Breach of fiduciary duty

Lawsuits brought on behalf of the corporation against its own officers and directors when those individuals breached their fiduciary duties to the company. Recovery typically takes the form of corporate governance reforms, recovery of misappropriated funds, and incentive awards to the shareholders who initiated the action.

03 · M&A Disclosure

Merger objection cases

Disclosure-based challenges to public-company mergers where the proxy statement omits or misstates material information that shareholders need to make an informed vote. These cases often result in additional disclosures and supplemental fees.

04 · Pre-Litigation Discovery

Books & records demands

Pre-litigation tools under Delaware General Corporation Law §220 (and state equivalents) that allow shareholders to inspect corporate records. We use these to investigate potential claims before they’re filed — a quieter, more surgical step than initiating litigation.

Active investigations

If you held shares in any of the companies below, you may have a claim.

Senti Biosciences Holdings

Investigating whether the proxy statement for Senti’s pending merger omits information shareholders need to evaluate the deal price.

Quartzsea Acquisition Corp.

Investigating disclosure adequacy in Quartzsea’s announced business combination and whether material terms were withheld from investors.

Emerald Holding, Inc.

Reviewing the proxy disclosures around Emerald’s proposed transaction for omissions material to a shareholder vote.

LiveRamp Holdings, Inc.

Investigating whether LiveRamp’s merger proxy adequately discloses the financial analyses underlying the board’s recommendation.

Mister Car Wash, Inc.

Examining the disclosures in Mister Car Wash’s announced merger and whether shareholders received the information needed for an informed vote.

More investigations

See the full list of companies under active review.

Cards render from the Investigation custom post type. Bind the card body to a curated card_summary field (one plain-English sentence) — not the post excerpt. Ticker pill = exchange + ticker. Show the red deadline pill only when a lead_plaintiff_deadline/vote_date is set; otherwise show “Open.” Issuer title stores company name only (no “— Shareholder Investigation” suffix).

Securities Class Actions · Derivative · M&A · §220 Demands

Active investigations

Promptly notify you of market losses that may stem from corporate fraud or misconduct.
Review your specific holdings against active and emerging investigations.
Assist filing claim forms in class action settlements where you are a class member.
Recommend appropriate action when we identify a recoverable loss.

Submitting your portfolio for monitoring does not create an attorney-client relationship.

Federal-court training

Confidential. Not shared with third parties.

Why investors work with us

Federal-court training

Securities cases are federal court cases. Our managing partner, Bob Amirian, clerked on the U.S. Court of Appeals for the Federal Circuit and trained at Venable LLP. The Federal Rules, the PSLRA pleading standard, and the discipline of federal motion practice are not new ground for us.

National practice from New York

We are based at 40 Wall Street in lower Manhattan. We represent investors across all 50 states and internationally.

Contingency fee, no out-of-pocket cost

Our representation in shareholder cases is on a contingency-fee basis. You do not pay legal fees or out-of-pocket expenses unless we recover for you. The terms are set out in a written retainer agreement that you review before signing.

Direct attorney communication

You will speak with the lawyer handling your matter. Amparo is structured to provide direct attorney access — not layers of intake staff.

Recent releases

01 · Securities Class Actions

Amparo Law Firm Investigates Senti Biosciences (SNTI) Merger for Potential Violations of Federal Securities Laws

Investors who held SNTI shares are encouraged to contact the firm regarding the pending merger and related proxy disclosures.

Press Release · May 16, 2026

Amparo Law Firm Investigates LiveRamp Holdings (RAMP) Merger for Potential Violations of Federal Securities Laws

Shareholders of LiveRamp may have claims relating to the disclosures in the company’s merger proxy. Contact the firm to learn more.

Point this loop at the published press-release / news post type, capped at 2. If the loop returns zero posts, hide the entire section with an Elementor display condition — never leave the heading over an empty band.

About the firm

Amparo Investor Rights is the investor protection practice of Amparo Law Firm PLLC, a New York-based plaintiff’s firm. The firm was founded by Bob Amirian, Esq., a federal appellate clerk and Venable LLP alumnus, and Jordan Sakni, an active New York real estate developer who serves as the firm’s Chief Operating Officer.

Jurisdiction-of-admission statement to be confirmed by counsel and matched verbatim in the footer disclosures (RPC 7.1).